Annual Current Liabilities
$654.80 M
+$117.10 M+21.78%
31 December 2023
Summary:
Neurocrine Biosciences annual total current liabilities is currently $654.80 million, with the most recent change of +$117.10 million (+21.78%) on 31 December 2023. During the last 3 years, it has risen by +$409.00 million (+166.40%). NBIX annual current liabilities is now at all-time high.NBIX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$429.70 M
+$31.20 M+7.83%
30 September 2024
Summary:
Neurocrine Biosciences quarterly total current liabilities is currently $429.70 million, with the most recent change of +$31.20 million (+7.83%) on 30 September 2024. Over the past year, it has dropped by -$225.10 million (-34.38%). NBIX quarterly current liabilities is now -39.73% below its all-time high of $712.90 million, reached on 31 March 2024.NBIX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -34.4% |
| 3 y3 years | +166.4% | +74.8% |
| 5 y5 years | +15.8% | -24.0% |
NBIX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +166.4% | -39.7% | +74.8% |
| 5 y | 5 years | at high | +251.1% | -39.7% | +206.3% |
| alltime | all time | at high | >+9999.0% | -39.7% | >+9999.0% |
Neurocrine Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $429.70 M(+7.8%) |
| June 2024 | - | $398.50 M(-44.1%) |
| Mar 2024 | - | $712.90 M(+8.9%) |
| Dec 2023 | $654.80 M(+21.8%) | $654.80 M(-5.3%) |
| Sept 2023 | - | $691.60 M(+18.7%) |
| June 2023 | - | $582.50 M(+55.7%) |
| Mar 2023 | - | $374.10 M(-30.4%) |
| Dec 2022 | $537.70 M(+118.8%) | $537.70 M(+10.8%) |
| Sept 2022 | - | $485.10 M(+69.8%) |
| June 2022 | - | $285.70 M(+12.7%) |
| Mar 2022 | - | $253.50 M(+3.1%) |
| Dec 2021 | $245.80 M(+31.8%) | $245.80 M(+8.8%) |
| Sept 2021 | - | $225.90 M(+6.1%) |
| June 2021 | - | $212.90 M(+12.1%) |
| Mar 2021 | - | $190.00 M(+1.9%) |
| Dec 2020 | $186.50 M(-67.0%) | $186.50 M(-69.5%) |
| Sept 2020 | - | $611.00 M(+6.6%) |
| June 2020 | - | $573.00 M(+308.4%) |
| Mar 2020 | - | $140.30 M(-75.2%) |
| Dec 2019 | $565.30 M(+540.7%) | $565.30 M(+388.8%) |
| Sept 2019 | - | $115.65 M(+15.0%) |
| June 2019 | - | $100.59 M(+39.7%) |
| Mar 2019 | - | $72.00 M(-18.4%) |
| Dec 2018 | $88.23 M(+62.1%) | $88.23 M(-80.7%) |
| Sept 2018 | - | $456.40 M(+639.0%) |
| June 2018 | - | $61.76 M(+32.9%) |
| Mar 2018 | - | $46.47 M(-14.6%) |
| Dec 2017 | $54.43 M(+79.0%) | $54.43 M(+42.7%) |
| Sept 2017 | - | $38.14 M(+37.6%) |
| June 2017 | - | $27.72 M(+17.6%) |
| Mar 2017 | - | $23.56 M(-22.5%) |
| Dec 2016 | $30.41 M(+18.3%) | $30.41 M(+14.1%) |
| Sept 2016 | - | $26.67 M(-0.9%) |
| June 2016 | - | $26.90 M(+15.6%) |
| Mar 2016 | - | $23.28 M(-9.5%) |
| Dec 2015 | $25.71 M(+64.2%) | $25.71 M(+29.7%) |
| Sept 2015 | - | $19.82 M(+12.9%) |
| June 2015 | - | $17.55 M(+15.6%) |
| Mar 2015 | - | $15.19 M(-3.0%) |
| Dec 2014 | $15.66 M(+33.9%) | $15.66 M(+11.5%) |
| Sept 2014 | - | $14.04 M(+16.5%) |
| June 2014 | - | $12.05 M(+13.6%) |
| Mar 2014 | - | $10.61 M(-9.3%) |
| Dec 2013 | $11.70 M(-25.2%) | $11.70 M(-12.2%) |
| Sept 2013 | - | $13.32 M(-8.6%) |
| June 2013 | - | $14.57 M(+5.0%) |
| Mar 2013 | - | $13.88 M(-11.3%) |
| Dec 2012 | $15.65 M(-66.8%) | $15.65 M(-32.3%) |
| Sept 2012 | - | $23.11 M(-20.7%) |
| June 2012 | - | $29.15 M(-20.4%) |
| Mar 2012 | - | $36.63 M(-22.2%) |
| Dec 2011 | $47.11 M(-10.7%) | $47.11 M(-2.8%) |
| Sept 2011 | - | $48.44 M(-3.1%) |
| June 2011 | - | $49.99 M(+2.0%) |
| Mar 2011 | - | $49.03 M(-7.1%) |
| Dec 2010 | $52.78 M | $52.78 M(-0.8%) |
| Sept 2010 | - | $53.18 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $52.12 M(+179.8%) |
| Mar 2010 | - | $18.63 M(-6.7%) |
| Dec 2009 | $19.96 M(-23.5%) | $19.96 M(-17.0%) |
| Sept 2009 | - | $24.04 M(-27.2%) |
| June 2009 | - | $33.02 M(+1.5%) |
| Mar 2009 | - | $32.54 M(+24.7%) |
| Dec 2008 | $26.09 M(-12.7%) | $26.09 M(+37.5%) |
| Sept 2008 | - | $18.98 M(-2.7%) |
| June 2008 | - | $19.49 M(+8.5%) |
| Mar 2008 | - | $17.97 M(-39.9%) |
| Dec 2007 | $29.91 M(+48.7%) | $29.91 M(+49.4%) |
| Sept 2007 | - | $20.02 M(+5.7%) |
| June 2007 | - | $18.94 M(+6.3%) |
| Mar 2007 | - | $17.82 M(-11.4%) |
| Dec 2006 | $20.12 M(-40.3%) | $20.12 M(-5.4%) |
| Sept 2006 | - | $21.27 M(-11.1%) |
| June 2006 | - | $23.93 M(-26.9%) |
| Mar 2006 | - | $32.76 M(-2.8%) |
| Dec 2005 | $33.69 M(-43.5%) | $33.69 M(-3.8%) |
| Sept 2005 | - | $35.04 M(-13.0%) |
| June 2005 | - | $40.29 M(-14.6%) |
| Mar 2005 | - | $47.18 M(-20.8%) |
| Dec 2004 | $59.59 M(-45.8%) | $59.59 M(-17.4%) |
| Sept 2004 | - | $72.11 M(+6.8%) |
| June 2004 | - | $67.50 M(-30.8%) |
| Mar 2004 | - | $97.54 M(-11.3%) |
| Dec 2003 | $110.01 M(+238.7%) | $110.01 M(-4.6%) |
| Sept 2003 | - | $115.27 M(+13.4%) |
| June 2003 | - | $101.61 M(+4.7%) |
| Mar 2003 | - | $97.08 M(+198.9%) |
| Dec 2002 | $32.48 M(+31.2%) | $32.48 M(+9.7%) |
| Sept 2002 | - | $29.61 M(+25.3%) |
| June 2002 | - | $23.63 M(-0.1%) |
| Mar 2002 | - | $23.66 M(-4.5%) |
| Dec 2001 | $24.76 M(+65.5%) | $24.76 M(+10.5%) |
| Sept 2001 | - | $22.41 M(+74.4%) |
| June 2001 | - | $12.85 M(+6.2%) |
| Mar 2001 | - | $12.09 M(-19.2%) |
| Dec 2000 | $14.96 M(+73.9%) | $14.96 M(+44.2%) |
| Sept 2000 | - | $10.38 M(+46.7%) |
| June 2000 | - | $7.07 M(-28.8%) |
| Mar 2000 | - | $9.93 M(+15.5%) |
| Dec 1999 | $8.60 M(+53.6%) | $8.60 M(+72.0%) |
| Sept 1999 | - | $5.00 M(+35.1%) |
| June 1999 | - | $3.70 M(0.0%) |
| Mar 1999 | - | $3.70 M(-33.9%) |
| Dec 1998 | $5.60 M(-20.0%) | $5.60 M(+9.8%) |
| Sept 1998 | - | $5.10 M(+50.0%) |
| June 1998 | - | $3.40 M(-29.2%) |
| Mar 1998 | - | $4.80 M(-31.4%) |
| Dec 1997 | $7.00 M(+70.7%) | $7.00 M(+32.1%) |
| Sept 1997 | - | $5.30 M(-3.6%) |
| June 1997 | - | $5.50 M(+22.2%) |
| Mar 1997 | - | $4.50 M(+9.8%) |
| Dec 1996 | $4.10 M | $4.10 M(+51.9%) |
| Sept 1996 | - | $2.70 M(-20.6%) |
| June 1996 | - | $3.40 M(+54.5%) |
| Mar 1996 | - | $2.20 M |
FAQ
- What is Neurocrine Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly current liabilities year-on-year change?
What is Neurocrine Biosciences annual total current liabilities?
The current annual current liabilities of NBIX is $654.80 M
What is the all time high annual current liabilities for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual total current liabilities is $654.80 M
What is Neurocrine Biosciences quarterly total current liabilities?
The current quarterly current liabilities of NBIX is $429.70 M
What is the all time high quarterly current liabilities for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly total current liabilities is $712.90 M
What is Neurocrine Biosciences quarterly current liabilities year-on-year change?
Over the past year, NBIX quarterly total current liabilities has changed by -$225.10 M (-34.38%)